RRC ID 47015
Author Saito T, Shime N, Itoh K, Fujita N, Saito Y, Shinozaki M, Shibuya K, Makimura K, Hashimoto S.
Title Disseminated aspergillosis following resolution of Pneumocystis pneumonia with sustained elevation of beta-glucan in an Intensive Care Unit: a case report.
Journal Infection
Abstract 100 pg/ml) refractory to trimethoprim-sulfamethoxazole and fosfluconazole may suggest possible Aspergillus infection and should prompt the initiation of empiric anti-aspergillosis therapies in patients at risk for fungal infection.
Volume 37(6)
Pages 547-50
Published 2009-12
DOI 10.1007/s15010-009-8108-5
PMID 19730788
MeSH Antifungal Agents / therapeutic use Aspergillosis / diagnosis* Aspergillosis / microbiology Aspergillosis / pathology Aspergillus / isolation & purification Brain / microbiology Fatal Outcome Female Heart / microbiology Humans Immunosuppressive Agents / adverse effects Immunosuppressive Agents / therapeutic use Intensive Care Units Lung / microbiology Mannans / blood Middle Aged Pneumocystis carinii / isolation & purification Pneumonia, Pneumocystis / diagnosis* Pneumonia, Pneumocystis / drug therapy* Pneumonia, Pneumocystis / microbiology Prednisolone / adverse effects Prednisolone / therapeutic use Trimethoprim, Sulfamethoxazole Drug Combination / therapeutic use beta-Glucans / blood*
IF 2.773
Times Cited 5
Pathogenic microorganisms ?